• 1
    Tassinari CA, Rubboli G, Volpi L, et al. Encephalopathy with electrical status epilepticus during slow sleep or ESES syndrome including the acquired aphasia. Clin Neurophysiol 2000;111(suppl. 2):S94S102.
  • 2
    De Negri M. Electrical status epilepticus during sleep (ESES). Different clinical syndromes: towards a unifying view? Brain Dev 1997;19(7):44751.
  • 3
    Maquet P, Hirsch E, Metz-Lutz MN, et al. Regional cerebral glucose metabolism in children with deterioration of one or more cognitive functions and continuous spike-and-wave discharges during sleep. Brain 1995;118(pt. 6):14971520.
  • 4
    Roulet Perez E. Syndromes of acquired epileptic aphasia and epilepsy with continuous spike-waves during sleep: models for prolonged cognitive impairment of epileptic origin. Semin Pediatr Neurol 1995;2(4):26977.
  • 5
    Veggiotti P, Termine C, Granocchio E, et al. Long-term neuropsychological follow-up and nosological considerations in five patients with Continuous Spikes and Waves during Slow Sleep. Epileptic Disord 2002;4(4):2439.
  • 6
    De Tiege X, Goldman S, Laureys S, et al. Regional cerebral glucose metabolism in epilepsies with continuous spikes and waves during sleep. Neurology 2004;63(5):8537.
  • 7
    Smith CM. Landau-Kleffner syndrome and CSWS. In: EngelJ, PedleyTA, eds. Epilepsy: a comprehensive textbook. Philadelphia : Lippincott-Raven Publishers, 1997: pp. 236777.
  • 8
    Saltik S, Uluduz D, Cokar O, et al. A clinical and EEG study on idiopathic partial epilepsies with evolution into ESES spectrum disorders. Epilepsia 2005;46(4):52433.
  • 9
    Marescaux C, Hirsch E, Finck S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia 1990;31(6):76877.
  • 10
    Paquier PF, Van Dongen HR, Loonen CB. The Landau-Kleffner syndrome or ‘acquired aphasia with convulsive disorder’. Long-term follow-up of six children and a review of the recent literature. Arch Neurol 1992;49(4):3549.
  • 11
    Pressler RM, Robinson RO, Wilson GA, et al. Treatment of interictal epileptiform discharges can improve behavior in children with behavioral problems and epilepsy. J Pediatr 2005;146(1):1127.
  • 12
    Laporte N, Sebire G, Gillerot Y, et al. Cognitive epilepsy: ADHD related to focal EEG discharges. Pediatr Neurol 2002;27(4):30711.
  • 13
    Hachad H, Ragueneau-Majlessi I, Levy RH. New antiepileptic drugs: review on drug interactions. Ther Drug Monit 2002;24(1):91103.
  • 14
    Coupez R, Nicolas JM, Browne TR. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid. Epilepsia 2003;44(2):1718.
  • 15
    French J. Use of levetiracetam in special populations. Epilepsia 2001;42(suppl. 4):403.
  • 16
    Lagae L, Buyse G, Deconinck A, et al. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Pediatr Neurol 2003;7(3):1238.
  • 17
    Wheless JW, Ng YT. Levetiracetam in refractory pediatric epilepsy. J Child Neurol 2002;17(6):4135.
  • 18
    Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure 2005;14(1):6671.
  • 19
    Gower AJ, Hirsch E, Boehrer A, et al. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 1995;22(3):20713.
  • 20
    Gorji A, Hohling JM, Madeja M, et al. Effect of levetiracetam on epileptiform discharges in human neocortical slices. Epilepsia 2002;43(12):14807.
  • 21
    Ben-Menachem E, Gilland E. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy. Seizure 2003;12(3):1315.
  • 22
    Stodieck S, Steinhoff BJ, Kolmsee S, et al. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges. Seizure 2001;10(8):5837.
  • 23
    Gallagher MJ, Eisenman LN, Brown KM, et al. Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy. Epilepsia 2004;45(1):901.
  • 24
    Duane DD. Increased frequency of rolandic spikes in ADHD children. Epilepsia 2004;45(5):5645; (author reply 565–566).
  • 25
    Capovilla G, Beccaria F, Cagdas S, et al. Efficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleep. Acta Neurol Scand 2004;110(3):1447.
  • 26
    Hoppen T, Sandrieser T, Rister M. Successful treatment of pharmacoresistent continuous spike wave activity during slow sleep with levetiracetam. Eur J Pediatr 2003;162(1):5961.
  • 27
    Tassinari CA, Rubboli G, Volpi L, et al. Electrical status epilepticus during slow wave sleep (ESES or CSWS) including acquired epileptic aphasia (Landau Kleffner syndrome). In: RogerJ, DravetC, GentonP, et al, eds. Epileptic syndromes in infancy, childhood and adolescence. 3rd ed. London : J. Libbey , 2002: 26583.
  • 28
    Massa R, De Saint-Martin A, Carcangiu R, et al. EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology 2001;57(6):10719.
  • 29
    Bast T, Volp A, Wolf C, et al. The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Epilepsia 2003;44(2):21520.
  • 30
    Galanopoulou AS, Bojko A, Lado F, et al. The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep. Brain Dev 2000;22(5):27995.
  • 31
    Kossoff EH, Boatman D, Freeman JM. Landau-Kleffner syndrome responsive to levetiracetam. Epilepsy Behav 2003;4(5):5715.
  • 32
    De Negri M, Baglietto MG, Battaglia FM, et al. Treatment of electrical status epilepticus by short diazepam (DZP) cycles after DZP rectal bolus test. Brain Dev 1995;17(5):3303.
  • 33
    Wakai S, Ito N, Ueda D, et al. Landau-Kleffner syndrome and sulthiame. Neuropediatrics 1997;28(2):1356.
  • 34
    Glauser TA. Topiramate in the catastrophic epilepsies of childhood. J Child Neurol 2000;15(suppl. 1):S1421.
  • 35
    Gross-Selbeck G. Treatment of “benign” partial epilepsies of childhood, including atypical forms. Neuropediatrics 1995;26(1):4550.
  • 36
    Lerman P, Lerman-Sagie T, Kivity S. Effect of early corticosteroid therapy for Landau-Kleffner syndrome. Dev Med Child Neurol 1991;33(3):25760.
  • 37
    Morrell F, Whisler WW, Smith MC, et al. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. Brain 1995;118(pt. 6):152946.
  • 38
    Irwin K, Birch V, Lees J, et al. Multiple subpial transection in Landau-Kleffner syndrome. Dev Med Child Neurol 2001;43(4):248252.
  • 39
    Shorvon S. Pyrrolidone derivatives. Lancet 2001;358(9296):188592.
  • 40
    Sankar R, Holmes GL. Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J Child Neurol 2004;19(suppl. 1):S614.
  • 41
    Klitgaard H, Pitkanen A. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam. Epileptic Disord 2003;5(suppl. 1):S916.